249 related articles for article (PubMed ID: 35646049)
1. Identification of Two m6A Readers
Li S; Wu Q; Liu J; Zhong Y
Front Genet; 2022; 13():903634. PubMed ID: 35646049
[No Abstract] [Full Text] [Related]
2. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of an m6A Reader Gene,
Deng X; Jiang Q; Liu Z; Chen W
Front Mol Biosci; 2020; 7():68. PubMed ID: 32391379
[TBL] [Abstract][Full Text] [Related]
4. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
6. Genomic and transcriptomic alterations in m6A regulatory genes are associated with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma.
Paramasivam A; George R; Priyadharsini JV
Am J Cancer Res; 2021; 11(7):3688-3697. PubMed ID: 34354868
[TBL] [Abstract][Full Text] [Related]
7. Potential Impact of ALKBH5 and YTHDF1 on Tumor Immunity in Colon Adenocarcinoma.
Yan G; An Y; Xu B; Wang N; Sun X; Sun M
Front Oncol; 2021; 11():670490. PubMed ID: 34079761
[TBL] [Abstract][Full Text] [Related]
8. Modification of m6A mediates tissue immune microenvironment in calcific aortic valve disease.
Chen JY; Xiong T; Sun YR; Cong J; Gong JS; Peng L; Rong YW; Wang ZY; Chang Q
Ann Transl Med; 2022 Sep; 10(17):931. PubMed ID: 36172101
[TBL] [Abstract][Full Text] [Related]
9. Landscape analysis of m6A modification regulators related biological functions and immune characteristics in myasthenia gravis.
Li S; Liu H; Ruan Z; Guo R; Sun C; Tang Y; Huang X; Gao T; Hao S; Li H; Song N; Su Y; Ning F; Li Z; Chang T
J Transl Med; 2023 Mar; 21(1):166. PubMed ID: 36864526
[TBL] [Abstract][Full Text] [Related]
10. IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma.
Hu Y; Chen J; Liu M; Feng Q; Peng H
Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36281789
[TBL] [Abstract][Full Text] [Related]
11. Machine learning-based solution reveals cuproptosis features in inflammatory bowel disease.
Liu L; Liang L; Yang C; Chen Y
Front Immunol; 2023; 14():1136991. PubMed ID: 37275904
[TBL] [Abstract][Full Text] [Related]
12. Upregulated YTHDF1 associates with tumor immune microenvironment in head and neck squamous cell carcinomas.
Huang Y; Liao J; Wu S; Ye Y; Zeng H; Liang F; Yin X; Jiang Y; Ouyang N; Han P; Huang X
Transl Cancer Res; 2022 Nov; 11(11):3986-3999. PubMed ID: 36523307
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analysis of the correlation between m6A RNA methylation regulators and the immune infiltration and prognosis of bladder cancer.
Wu J; Wang X; Xu H; Tian J; Ji H; Zhu J; Guo H; Chen Z
Ann Transl Med; 2022 Dec; 10(24):1386. PubMed ID: 36660722
[TBL] [Abstract][Full Text] [Related]
14. The analysis of N6-methyladenosine regulators impacting the immune infiltration in clear cell renal cell carcinoma.
Li J; Cao J; Liang C; Deng R; Li P; Tian J
Med Oncol; 2022 Jan; 39(4):41. PubMed ID: 35092501
[TBL] [Abstract][Full Text] [Related]
15. Molecular Characteristics, Prognostic Value, and Immune Characteristics of m
Geng X; Zhang Y; Zeng Z; Zhu Z; Wang H; Yu W; Li Q
Front Oncol; 2021; 11():629718. PubMed ID: 33816266
[TBL] [Abstract][Full Text] [Related]
16. Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma.
Chen D; Guo W; Yu H; Yang J
Transl Cancer Res; 2022 Sep; 11(9):3064-3079. PubMed ID: 36237271
[TBL] [Abstract][Full Text] [Related]
17. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer.
Zhao H; Xu Y; Xie Y; Zhang L; Gao M; Li S; Wang F
Front Cell Dev Biol; 2021; 9():650023. PubMed ID: 33748145
[TBL] [Abstract][Full Text] [Related]
18. Significance of RNA N6-methyladenosine regulators in the diagnosis and subtype classification of coronary heart disease using the Gene Expression Omnibus database.
Jiang Y; Pan Y; Long T; Qi J; Liu J; Zhang M
Front Cardiovasc Med; 2023; 10():1185873. PubMed ID: 37928762
[TBL] [Abstract][Full Text] [Related]
19. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
Zhou Y; Yin Z; Hou B; Yu M; Chen R; Jin H; Jian Z
Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805
[No Abstract] [Full Text] [Related]
20. Gene model-related m6A expression levels predict the risk of preeclampsia.
Li Y; Chen C; Diao M; Wei Y; Zhu Y; Hu W
BMC Med Genomics; 2022 May; 15(1):103. PubMed ID: 35513840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
